4 studies found for:    AIR001
Show Display Options
Rank Status Study
1 Terminated Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001
2 Completed Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sodium Nitrite Inhalation Solution;   Drug: Placebo and AIR001 Inhalation Solution (Expansion arm)
3 Terminated A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001 (sodium nitrite inhalation solution)
4 Completed Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
Conditions: Pulmonary Hypertension;   Pulmonary Arterial Hypertension
Interventions: Drug: 15 mg sodium nitrite inhalation solution;   Drug: 90 mg sodium nitrite inhalation solution;   Drug: 45 mg sodium nitrite inhalation solution;   Drug: 120 mg sodium nitrite inhalation solution;   Drug: 25% MTD sodium nitrite inhalation solution

Indicates status has not been verified in more than two years